Skip to main content
OpenTrials

Clinical trial condition

Hyperlipoproteinemias

Explore clinical trials studying Hyperlipoproteinemias. Study availability and eligibility vary by location and protocol.

231 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Hyperlipoproteinemias trial results

Completed

Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients

NCT03747224

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +10 more
Locations
  • Research Site 2 Camperdown, New South Wales, Australia
  • Research Site 3 Adelaide, South Australia, Australia
  • Research Site 1 Nedlands, Australia
  • Research Site 4 Grafton, Auckland, New Zealand
View Trial Details
Completed

Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS)

NCT03783377

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Chylomicronemia, +10 more
Locations
  • Research Site 2 Camperdown, New South Wales, Australia
  • Research Site 5 Sippy Downs, Queensland, Australia
  • Research Site 3 Adelaide, South Australia, Australia
  • Research Site 4 Perth, Washington, Australia
View Trial Details
Completed

A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in Taiwan

NCT06925100

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • Far Eastern Memorial Hospital New Taipei City, Taiwan
  • Linkou Chang Gung Memorial Hospital Taoyuan, Taiwan
View Trial Details
Completed

Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies

NCT06005597

Conditions
ASCVD, Arterial Occlusive Diseases, Arteriosclerosis, +17 more
Locations
  • East Valley Diabetes & Endocrinology Gilbert, Arizona, United States
  • Jacksonville Center for Clinical Research Jacksonville, Florida, United States
  • Progressive Medical Research Port Orange, Florida, United States
  • Centricity Research - Columbus Columbus, Georgia, United States
View all 45 locations
View Trial Details
Completed

Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies

NCT05142722

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +17 more
Locations
  • Pinnacle Research Group Anniston, Alabama, United States
  • Central Alabama Research Birmingham, Alabama, United States
  • Synexus Clinical Research US, Inc. / Simon Williamson Clinic, PC Birmingham, Alabama, United States
  • The Center for Clinical Trials, Inc Saraland, Alabama, United States
View all 181 locations
View Trial Details
Completed

A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids

NCT05952856

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +10 more
Locations
  • Alliance for Multispecialty Research, LLC ( Site 0093) Daphne, Alabama, United States
  • G&L Research ( Site 0043) Foley, Alabama, United States
  • Synexus Clinical Research US, Inc.-Synexus Clinical Research US, Inc - Central Phoenix ( Site 0084) Phoenix, Arizona, United States
  • National Heart Institute-Research ( Site 0087) Beverly Hills, California, United States
View all 168 locations
View Trial Details

Related conditions